No Detail Found!

Molecular docking, synthesis and biological evaluation of ergosteryl- ferulate as a HMG-CoA reductase inhibitor

Author(s)
Syaikhul Aziz Department of Pharmacy, Faculty of Science, Institut Teknologi Sumatera,Indonesia; Pharmaceutical Biology Research Group, School of Pharmacy, Institut Teknologi Bandung,Indonesia
Elfahmi Pharmaceutical Biology Research Group, School of Pharmacy, Institut Teknologi Bandung,Indonesia
Andreanus A Soemardji Pharmacology-Clinical Pharmacy Research Group, School of Pharmacy, Institut Teknologi Bandung,Indonesia
Sukrasno Pharmaceutical Biology Research Group, School of Pharmacy, Institut Teknologi Bandung,Indonesia
Abstract
In the present study, ergosteryl-ferulate (5), oryzanol analog was evaluated for its possibility as the inhibitor of HMG-CoA reductase (HMGR), through in silico and in vitro approach. Firstly, the study was conducted through molecular docking simulation using AutoDock Tools software to predict the interaction of 5 in complexes with HMGR. In addition, four major compounds of oryzanol (1-4) were employed as a comparison. Secondly, 5 was synthesized through esterification using thionyl chloride as an activator. Lastly, 5 was evaluated for its capacity to inhibit HMGR activity using HMGR assay kit. Molecular docking simulation results suggest that oryzanol (1-4) and 5 exhibited a binding affinity against HMGR. The activity of 5 was predicted to be the best among the oryzanol compounds (1-4), in which, the free binding energy and inhibition constant were -4.17 kcal/mol and 0.88mM. The in vitro assay showed that 5 had inhibitory activity against HMGR 1.93 times higher than oryzanol. In summary, 5 has more potential candidates for HMGR inhibitor than oryzanol.
Publication Details
Page(s) 997-1003
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 33, Issue: 3, Year: 2020

Request the full text from PASTIC

Keywords
ergosteryl-ferulate
0

Citations

0

Downloads

65

Views